查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991412

2026-2034年全球仿生眼市場規模、佔有率、趨勢及成長分析報告

Global Bionic Eye Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 108 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

仿生眼市場預計將從 2025 年的 4.0447 億美元成長到 2034 年的 12.9571 億美元，2026 年至 2034 年的複合年成長率為 13.81%。

全球仿生眼市場正迅速崛起，成為醫療技術領域一個突破性的細分市場，專注於為重度視力障礙患者恢復視力。仿生眼利用先進的電子植入和視覺處理系統來刺激視網膜和視神經，使患者能夠識別光線和基本形狀。生物醫學工程和神經技術的快速發展正推動創新視覺假體系統的研發，逐步改變視力喪失的治療方案。

主要成長要素包括視網膜色素變性和老齡化黃斑部病變等視網膜退化性疾病病例的增加。醫療研發投入的增加以及先進植入式技術的廣泛應用也推動了市場成長。科技公司、醫療機構和研究組織之間的合作正在加速仿生眼系統的發展，提高其安全性和功能性。

隨著研究人員不斷改進植入式技術和神經介面，仿生眼市場前景極為光明。人工智慧、微電子和無線通訊技術的進步有望提升患者的影像處理能力和視覺清晰度。隨著臨床試驗的擴展和監管核准的增加，更多患者將能夠獲得這些創新解決方案。持續進行的恢復功能性視力的研究有望推動更多突破和市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球仿生眼市場：依類型分類

  • 市場分析、洞察與預測
  • 外部類型
  • 嵌入式

第5章：全球仿生眼市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診設施
  • 研究/製造

第6章 全球仿生眼市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Second Sight Medical Products LLC
    • NIDEK Co. Ltd
    • Nano Retina Ltd
    • MetaModal LLC
    • Biomedical Technologies SL
    • Bionic Vision Technologies Pty Ltd
    • Pixium Vision SA
    • Monash Vision Group
簡介目錄
Product Code: VMR11213792

The Bionic Eye Market size is expected to reach USD 1295.71 Million in 2034 from USD 404.47 Million (2025) growing at a CAGR of 13.81% during 2026-2034.

The global bionic eye market has emerged as a groundbreaking segment within medical technology, focusing on restoring vision for individuals with severe visual impairments. Bionic eyes use advanced electronic implants and visual processing systems to stimulate the retina or optic nerve, enabling patients to perceive light and basic shapes. Rapid progress in biomedical engineering and neurotechnology has contributed to the development of innovative visual prosthetic systems, gradually transforming treatment options for vision loss.

Key growth drivers include increasing cases of retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. Growing investments in medical research and the rising adoption of advanced implantable technologies are also supporting market development. Collaboration between technology companies, healthcare institutions, and research organizations has accelerated the advancement of bionic eye systems, improving their safety and functionality.

The future of the bionic eye market holds significant promise as researchers continue to refine implant technologies and neural interfaces. Advances in artificial intelligence, microelectronics, and wireless communication could enhance image processing and visual clarity for patients. As clinical trials expand and regulatory approvals increase, more patients may gain access to these innovative solutions. The continued pursuit of restoring functional vision is expected to drive further breakthroughs and market growth.

MARKET SEGMENTATION

By Type

  • External Eye
  • Implanted Eye

By End Use

  • Hospitals
  • Outpatient Facilities
  • Research And Manufacturing

COMPANIES PROFILED

  • Second Sight Medical Products LLC, NIDEK Co Ltd, Nano Retina Ltd, MetaModal LLC, Biomedical Technologies SL, Bionic Vision Technologies Pty Ltd, Pixium Vision SA, Monash Vision Group
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIONIC EYE MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. External Eye Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Implanted Eye Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIONIC EYE MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Research And Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIONIC EYE MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIONIC EYE INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Second Sight Medical Products LLC
    • 8.2.2 NIDEK Co. Ltd
    • 8.2.3 Nano Retina Ltd
    • 8.2.4 MetaModal LLC
    • 8.2.5 Biomedical Technologies S.L
    • 8.2.6 Bionic Vision Technologies Pty Ltd
    • 8.2.7 Pixium Vision SA
    • 8.2.8 Monash Vision Group